RecruitingNCT06182436
Virtual reality or standard care during dupilumab injections for children
About this title
Read the official source — NCT06182436Device studyAges 6–17CanadaAnxiety
Understand this study
Who could participate?
Listed age limits: 6 years to 17 years.
- Listed locations
- Montreal and 1 more locationSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 16, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 98
- Sponsor
- St. Justine's Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Device
- Intervention type
- Device, Other
- Locations
- Canada
- Age range
- From 6 Years to 17 Years
- Official registry ID
- NCT06182436
- Official title
Show the full official title
Use of Virtual Reality to Improve Pain and Anxiety Management of Children During Dupilumab Injection for Atopic Dermatitis (VR-DERMA)
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Montreal
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is St. Justine's Hospital, a hospital or academic medical center.
Who can participate?
Listed age limits: 6 years to 17 years.
Is this study still recruiting?
The registry lists this study as recruiting.
